Correspondence between stone composition and urine supersaturation in nephrolithiasis - PubMed (original) (raw)
. 1997 Mar;51(3):894-900.
doi: 10.1038/ki.1997.126.
Affiliations
- PMID: 9067927
- DOI: 10.1038/ki.1997.126
Free article
Correspondence between stone composition and urine supersaturation in nephrolithiasis
J H Parks et al. Kidney Int. 1997 Mar.
Free article
Abstract
Supersaturation (SS) with respect to calcium oxalate monohydrate (COM), brushite (Br) and uric acid (UA), obtained in three 24-hour pretreatment urine samples from patients with stone disease were compared to the mineral composition of stones passed by the same patients to determine whether sparse urine SS measurements accurately reflect the long-term average SS values in the kidney and final urine. Among males and females elevation of SS above same sex normals corresponded to composition. As well, treatments that reduced stone rates also reduced these SS values. The degree of calcium phosphate (CaP) admixture was accurately matched by shifting magnitudes of COM and Br SS. As well, increasing CaP content was associated with falling urine citrate and rising urine pH, suggesting renal tubular acidosis. We conclude that sparse urine SS measurements accurately track stone admixtures, and are a reliable index of average renal and urine SS.
Similar articles
- Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR, Parks JH, Coe FL. Asplin JR, et al. Kidney Int. 1997 Dec;52(6):1602-8. doi: 10.1038/ki.1997.491. Kidney Int. 1997. PMID: 9407506 - Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA. Krieger NS, et al. J Am Soc Nephrol. 2015 Dec;26(12):3001-8. doi: 10.1681/ASN.2014121223. Epub 2015 Apr 8. J Am Soc Nephrol. 2015. PMID: 25855777 Free PMC article. - Evaluation of factors involved in calcium stone formation.
Abraham PA, Smith CL. Abraham PA, et al. Miner Electrolyte Metab. 1987;13(3):201-8. Miner Electrolyte Metab. 1987. PMID: 3627051 - Citrate therapy for calcium phosphate stones.
Rimer JD, Sakhaee K, Maalouf NM. Rimer JD, et al. Curr Opin Nephrol Hypertens. 2019 Mar;28(2):130-139. doi: 10.1097/MNH.0000000000000474. Curr Opin Nephrol Hypertens. 2019. PMID: 30531474 Review. - Biopathological crystallization: a general view about the mechanisms of renal stone formation.
Grases F, Costa-Bauzá A, García-Ferragut L. Grases F, et al. Adv Colloid Interface Sci. 1998 Feb;74:169-94. doi: 10.1016/s0001-8686(97)00041-9. Adv Colloid Interface Sci. 1998. PMID: 9561720 Review.
Cited by
- The Conundrum of Alkali Therapy in Calcium Phosphate Stone Formers.
Yau AA. Yau AA. Kidney Int Rep. 2023 Dec 26;9(3):721-724. doi: 10.1016/j.ekir.2023.12.020. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481489 Free PMC article. No abstract available. - Urinary supersaturation in a Randomized trial among Individuals with Nephrolithiasis comparing Empiric versus selective therapy (URINE): design and rationale of a clinical trial.
Hsi RS, Koyama T, Silver HJ, Goldfarb DS. Hsi RS, et al. Urolithiasis. 2023 Jan 4;51(1):28. doi: 10.1007/s00240-022-01400-8. Urolithiasis. 2023. PMID: 36598705 Free PMC article. Clinical Trial. - International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.
Zeng G, Zhu W, Robertson WG, Penniston KL, Smith D, Pozdzik A, Tefik T, Prezioso D, Pearle MS, Chew BH, Veser J, Fiori C, Deng Y, Straub M, Türk C, Semins MJ, Wang K, Marangella M, Jia Z, Zhang L, Ye Z, Tiselius HG, Sarica K. Zeng G, et al. Urolithiasis. 2022 Dec 1;51(1):4. doi: 10.1007/s00240-022-01387-2. Urolithiasis. 2022. PMID: 36454329 Review. - Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.
Mikel CC, Goldfarb DS, Ponte A, Steigelman K, Latyshev S. Mikel CC, et al. Urolithiasis. 2022 Dec;50(6):721-727. doi: 10.1007/s00240-022-01364-9. Epub 2022 Oct 6. Urolithiasis. 2022. PMID: 36201021 Free PMC article. - Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1.
Matsuura K, Maehara N, Hirota A, Eguchi A, Yasuda K, Taniguchi K, Nishijima A, Matsuhashi N, Shiga Y, Ishii R, Iguchi Y, Tanabe K, Arai S, Miyazaki T. Matsuura K, et al. Commun Biol. 2022 Aug 3;5(1):783. doi: 10.1038/s42003-022-03750-w. Commun Biol. 2022. PMID: 35922481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous